Resources
For the latest in nextgen biomed, sign up for our monthly newsletter to be among the first to receive exclusive insights, in-depth market analyses, and expert articles directly to your inbox

See how top pharma players are addressing impure, unstable, and off-target oligos

Boosting the Efficacy of Safe, Scalable, & Precise Vaccines
Innovations in mRNA Technology, RNA Therapeutics, and Cancer Immunotherapy for 2024
.png)
Tumbler: A Highly Customizable Antibody Optimization Suite
On-demand presentation, presented by Michali Izhaky, Bioinformatics Scientist at Charles River

Leading Innovations in Fab, ScFv, & VHH Production and Engineering
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics

Advancing Immunotherapy: The Critical Role of GMP-Grade Cytokines in Cell Therapy
On-demand webinar presented by Ritwika Biswas, Field Application Scientist at Sino Biological

Optimizing Bispecific Antibody Production: From Identifying Optimal Pairings to Scale-up Processes
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics

Unlocking the Future of Immune Cancer Therapy
A concise report featuring insights from the prominent though leaders of Immuno 2024.

Stem Cell Therapy
Spinal Stem Cells 'Lure' Tumours to the Spine, Study Shows
An animal model study suggests that cells produced by breast cancer preferentially metastasize to the spine over other bones in the body, with key proteins identified as affecting spinal tropism.

Tumour Microenvironment
Positive Phase I Data from Oncolytic Virotherapy Trial
TILT-123, an oncolytic virotherapy, has shown promising results from a phase I clinical trial which treats solid tumours in patients that have exhausted other options.

Antibody & Protein Engineering
Post-Event Proceedings - Biologics 2023
Concise and insightful summaries of presentations delivered by prominent thought leaders at Biologics 2023

Drug Discovery & Development
Bispecific Antibody Format: Interview with Laura von Schantz, Chief Technology Officer, Alligator Biosciences
Talking with Laura von Schantz, Chief Technology Officer, at Alligator Biosciences about their RUBY bispecific antibody format.

Immuno-Oncology
10x Genomics: Inside Visium Spatial Capture Technology
Visium Spatial Gene Expression incorporates whole transcriptome analysis for intact tissues sections with morphological context. Bringing these complementary methods together offers a previously inaccessible view of tissue biology.
Subscribe to Our Newsletter
Sign up for our monthly newsletter to
keep up with all things discovery